Kentucky LEADS Collaborative: Lung Cancer Survivorship Care Program

The study design is a single-arm clinical trial, or a prospective cohort design, where a
longitudinal series of data will be collected from participants. Participants will be
consented and asked to complete a baseline questionnaire (PRE) which includes topics
measuring quality of life, distress, symptom management, social support, healthy behaviors,
demographics and health history. Two similar questionnaires will be administered after
exposure to the Survivorship Care Program (POST and FOL). In addition, the consent form
requests permission from survivors to collect clinical data from medical records and the
Kentucky Cancer Registry regarding diagnosis and treatment for lung cancer. The study will
enroll 300 participants, with an estimate of approximately 30 participants enrolled at each
site. However, if a participating site enrolls 30 participants and the overall study accrual
has not yet been met, the study PI may allow that respective participating site to continue
to enroll participants. Study accrual is competitive across participating sites until the
overall study accrual has been met.

Inclusion Criteria:

- Individuals who have been diagnosed with lung cancer (survivor) or

- Caregiver of a participating lung cancer survivor

- Ability to read and write in English

Exclusion Criteria:

- Individuals with significant psychiatric disturbance that requires a higher level of
care

- Individuals with substance abuse/dependence problem that require a higher level of
care

- Incarcerate individuals or individuals detained within the legal system